Advanced Cancer Clinical Trials in Shanghai, Shanghai Municipality
9 recruitingShanghai, Shanghai Municipality, China
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Advanced CancerAdvanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.202 enrolled2 locationsNCT06656390
Recruiting
Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.86 enrolled5 locationsNCT07269145
Recruiting
Phase 2
HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC
Advanced CancerICC
Eastern Hepatobiliary Surgery Hospital50 enrolled1 locationNCT07364305
Recruiting
Phase 1Phase 2
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Advanced Cancer
Suzhou Transcenta Therapeutics Co., Ltd.320 enrolled40 locationsNCT04495296
Recruiting
Phase 1
Clinical Trial of TQB3002 in Patients With Advanced Cancers
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.150 enrolled11 locationsNCT06662760
Recruiting
Phase 1
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
Advanced Cancer
HC Biopharma Inc.252 enrolled1 locationNCT06963814
Recruiting
Phase 1
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.150 enrolled17 locationsNCT06188624
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805